ArticleJournal of medical case reports2026
Neurosarcoidosis presenting with panhypopituitarism: diagnostic and therapeutic challenges: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeurosarcoidosis is a rare but serious manifestation of sarcoidosis involving the central nervous system. When it affects the hypothalamic-pituitary axis, it can result in panhypopituitarism and diabetes insipidus due to disruption of anterior and posterior pituitary hormone regulation. Early recognition is critical, as delayed diagnosis may lead to life-threatening complications. CASE PRESENTATION: We report the case of a 42-year-old White man with a 12-year history of sarcoidosis who presented with abdominal pain, hypotension, hypothermia, hypernatremia, polyuria, and polydipsia. He also had widespread skin plaques, joint pain, and cartilage deformities. Notably, he had developed drug-resistant seizures 3 years earlier. Laboratory investigations demonstrated hypernatremia, low urine osmolality, and hormonal deficiencies consistent with panhypopituitarism. Imaging revealed suprasellar and brainstem lesions. After excluding alternative diagnoses, neurosarcoidosis was established. The patient responded well to hormone replacement therapy with levothyroxine and desmopressin, which led to clinical improvement.
conclusionThis case highlights the importance of considering neurosarcoidosis in patients with sarcoidosis who develop endocrine or neurological symptoms. It underscores the value of timely diagnosis and multidisciplinary management to prevent irreversible complications and improve long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.